Artificial intelligence (AI) isn't the only industry with explosive growth potential.

What did the recent study using the crispr gene editing technique actually entail, and what did we learn from it? Hosted by: Hank Green Dooblydoo thanks go to the following Patreon supporters: Kevin ...

CRISPR Therapeutics AG (NASDAQ:CRSP) is among the Growth Stock Portfolio: 12 Stock Picks By Cathie Wood. On January 22, 2026, ...

CRISPR Therapeutics heads into Q4 earnings with rising Casgevy sales, collaboration revenues from Vertex, and a history of beating estimates.

Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunru crafted a bespoke treatment that has successfully corrected the genetic ...

Sen. Ron Johnson (R-Wis.) on Tuesday said the suspected biological research lab found in Las Vegas poses an “enormous problem ...

How CRISPR and functional genomics are used to establish causality, understand disease mechanisms and guide early drug ...

In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.

Gene-editing citrus fruits to make them less bitter could not only encourage more people to eat them, it might also help save the industry from a devastating plague ...

The average one-year price target for CRISPR Therapeutics (NasdaqGM:CRSP) has been revised to $82.91 / share. This is an ...

A research team has successfully demonstrated the world's first gene-editing treatment for Leber's hereditary optic ...

Explore groundbreaking gene-editing therapy for kidney disease, offering hope to those with polycystic kidney disease.